Red Biotechnology
Insights
Published on 30. January 2022
449 pages
978-1-77469-341-4 (ISBN)
Description
The statistics of health issues coupled with the COVID-19 pandemic that is devastating mankind across several spheres raise concerns about our health and wellbeing. This brings in the field of medical biotechnology or red biotechnology that is aimed at employing biotechnology to address diseases and malignancies. This book summarizes the aspects of vaccination with a chapter dedicated to the status of research of vaccination for COVID-19. The book also includes the latest approaches such as bispecific antibodies, their promise and their current status. Another interesting field is regenerative medicine that looks at restoring lost or damaged functions employing stem cells, growth factors, tissue regeneration and bioprinting of organs.
More details
Language
English
Place of publication
Oakville
Canada
Publishing group
Arcler Press
Target group
Professional and scholarly
File size
28,96 MB
ISBN-13
978-1-77469-341-4 (9781774693414)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Person
ShivSanjeevi Sripathi completed his Masters in Biotechnology from Mumbai University in 2008. He was awarded for academic excellence in both his Bachelors and Masters for securing second rank in Mumbai University in 2006 and first rank in his college: Kishinchand chellaram College. For his Masters he secured first rank in his college KET's V.G.Vaze College. He qualified CSIR and NET and and TOEFL in September 2008. He then worked on a stem cell project at the Specialized Centre for Cell Based Therapy (SCCT),KEM Hospital at Mumbai on a project entitled,: Isolation & detection of stem cells from Human Umbilical cord/ amniotic membrane" following which he worked at Junior Research Fellow at Microbiology & Cell Biology Department, Indian Institute of Science, Bangalore on cloning of cell wall genes and transcription factors in E.coli & M.smegmatis. As a writer, he has authored and co-authored 35 books on various aspects of biology such as bionics, molecular wires, cloning, hypertension, the epidemics of the 21st century, handling depression, camouflage, hygiene, immunology and many more with international publishers. He loves to read and share on interesting aspects of life sciences in books. In his free time he loves to travel and explore and give talks on spirituality, ancient customs and traditions.
Content
Chapter 1 Red Biotechnology Introduction and Vaccines
Chapter 2 COVID-19 Vaccines: Approaches and Status
Chapter 3 Monoclonal Antibodies Today
Chapter 4 Other Technologies: A Snapshot
Chapter 5 Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders
Chapter 6 From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape
Chapter 7 Phage Display Derived Monoclonal Antibodies: From Bench to Bedside
Chapter 8 3D Printing of Bioreactors in Tissue Engineering: A Generalised Approach
Chapter 9 Integrated Cancer Tissue Engineering Models for Precision Medicine
Chapter 10 Organ-on-a-chip: Recent Breakthroughs and Future Prospects
Chapter 2 COVID-19 Vaccines: Approaches and Status
Chapter 3 Monoclonal Antibodies Today
Chapter 4 Other Technologies: A Snapshot
Chapter 5 Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders
Chapter 6 From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape
Chapter 7 Phage Display Derived Monoclonal Antibodies: From Bench to Bedside
Chapter 8 3D Printing of Bioreactors in Tissue Engineering: A Generalised Approach
Chapter 9 Integrated Cancer Tissue Engineering Models for Precision Medicine
Chapter 10 Organ-on-a-chip: Recent Breakthroughs and Future Prospects
